<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39380114</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-2994</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Antimicrobial resistance and infection control</Title><ISOAbbreviation>Antimicrob Resist Infect Control</ISOAbbreviation></Journal><ArticleTitle>Increase in PVC-BSI during the second COVID-19 pandemic year: analysis of catheter and patient characteristics.</ArticleTitle><Pagination><StartPage>120</StartPage><MedlinePgn>120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13756-024-01476-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Increasing nosocomial infections during the COVID-19 pandemic have been reported. However, data describing peripheral venous catheter associated bloodstream infections (PVC-BSI) are limited.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To describe the epidemiology and risk factors for PVC-BSI during the COVID-19 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted retrospective cohort study of prospectively collected PVC-BSI data in a 2100 bed hospital network in Switzerland. Adult patients with a PVC inserted between January 1, 2020 and December 31, 2021 were included. Risk factors for PVC-BSI were identified through descriptive analysis of patient and catheter characteristics, and univariable marginal Cox models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">206,804 PVCs and 37 PVC-BSI were analysed. Most PVC-BSI were attributed to catheters inserted in the Emergency department (76%) or surgical wards (22%). PVC-BSI increased in 2021 compared to 2020 (hazard ratio 2021 vs. 2020 = 2.73; 95% confidence interval 1.19-6.29), with a numerically higher rate of Staphylococcus aureus (1/10, 10%, vs. 5/27, 19%) and polymicrobial infection (0/10, 0% vs. 4/27, 15%). PVC insertions, patient characteristics, and catheter characteristics remained similar across the study period. PVC-BSI risk was associated with admission to the intensive care unit (ICU), and use of wide gauge catheter ( &lt; = 16G).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Increased PVC-BSI during the COVID-19 pandemic was not explained by catheter or patient factors alone, and may result from system-wide changes. PVC-BSI events are primarily attributed to acute care settings, including the emergency department, surgical wards, and the ICU.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Pianca</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zanella</LastName><ForeName>Marie-Céline</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obama</LastName><ForeName>Basilice Minka</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Aude</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortchantre</LastName><ForeName>Loïc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chraiti</LastName><ForeName>Marie-Noëlle</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harbarth</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catho</LastName><ForeName>Gaud</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>MacPhail</LastName><ForeName>Aleece</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland. aleece.macphail@monash.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Monash Health, 246 Clayton Road Clayton, Melbourne, 3168, Australia. aleece.macphail@monash.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. aleece.macphail@monash.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Buetti</LastName><ForeName>Niccolò</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection Antimicrobials Modeling Evolution (IAME), INSERM, Université Paris-Cité, Paris, U 1137, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Resist Infect Control</MedlineTA><NlmUniqueID>101585411</NlmUniqueID><ISSNLinking>2047-2994</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013557" MajorTopicYN="N" Type="Geographic">Switzerland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055499" MajorTopicYN="Y">Catheter-Related Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002406" MajorTopicYN="Y">Catheterization, Peripheral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Catheter-associated bloodstream infection</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Peripheral venous catheters</Keyword></KeywordList><CoiStatement>None to declare. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380114</ArticleId><ArticleId IdType="pmc">PMC11463163</ArticleId><ArticleId IdType="doi">10.1186/s13756-024-01476-4</ArticleId><ArticleId IdType="pii">10.1186/s13756-024-01476-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mermel LA. Short-term peripheral venous catheter–related bloodstream infections: a systematic review. Clin Infect Dis. 2017;65(10):1757–62.</Citation><ArticleIdList><ArticleId IdType="pubmed">29020252</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugeon B, Guenezan J, Pichon M, Devos A, Fouassin X, Neveu A, et al. Incidence, complications, and costs of peripheral venous catheter-related bacteraemia: a retrospective, single-centre study. J Hosp Infect. 2023;135:67–73.</Citation><ArticleIdList><ArticleId IdType="pubmed">36918069</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujol M, Hornero A, Saballs M, Argerich M, Verdaguer R, Cisnal M, et al. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. J Hosp Infect. 2007;67(1):22–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17719678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingg W, Pittet D. Peripheral venous catheters: an under-evaluated problem. Int J Antimicrob Agents. 2009;34:S38–42.</Citation><ArticleIdList><ArticleId IdType="pubmed">19931816</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker MA, Sands KE, Huang SS, Kleinman K, Septimus EJ, Varma N, et al. The impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated infections. Clin Infect Dis. 2021;74(10):1748–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385925</ArticleId><ArticleId IdType="pubmed">34370014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Aderet MA, Madhusudhan MS, Haroun P, Almario MJ, Raypon R, Fawcett S, et al. Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line–associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic. Infection Control &amp; Hospital Epidemiology; 2022. pp. 1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10369209</ArticleId><ArticleId IdType="pubmed">36043349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanella M-C, Pianca E, Catho G, Obama B, De Kraker ME, Nguyen A, et al. Increased peripheral venous catheter bloodstream infections during COVID-19 pandemic, Switzerland. Emerg Infect Dis. 2024;30(1):159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10756358</ArticleId><ArticleId IdType="pubmed">38063084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsuno K, Ikeda M, Wakabayashi Y, Yanagimoto S, Okugawa S, Moriya K. Clinical Features of Bloodstream Infections Associated with Peripheral Versus Central venous catheters. Infect Dis Therapy. 2019;8(3):343–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6702512</ArticleId><ArticleId IdType="pubmed">31368046</ArticleId></ArticleIdList></Reference><Reference><Citation>Buetti N, Abbas M, Pittet D, de Kraker ME, Teixeira D, Chraiti M-N, et al. Comparison of routine replacement with clinically indicated replacement of peripheral intravenous catheters. JAMA Intern Med. 2021;181(11):1471–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8561330</ArticleId><ArticleId IdType="pubmed">34533191</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control. Surveillance of healthcare-associated infections and prevention indicators in European intensive care units. 2017 https://ecdc.europa.eu/sites/portal/files/documents/HAI-Net-ICU-protocol-v2.2_0.pdf</Citation></Reference><Reference><Citation>Swiss Confederation Hospital-based COVID-19 Surveillance (CH-SUR). Hospital-based surveillance of COVID-19 in Switzerland… 2022 31.12.2023 [cited 2023 14.05.2023]; https://www.unige.ch/medecine/hospital-covid/</Citation></Reference><Reference><Citation>Thiabaud A, Iten A, Balmelli C, Senn L, Troillet N, Widmer A, et al. Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland. Swiss Med Wkly. 2021;151:w20475.</Citation><ArticleIdList><ArticleId IdType="pubmed">33638351</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang A, Thakker R, Li S, Hommel E, Mehta HB, Goodwin JS. Hospitalizations and mortality from non–SARS-CoV-2 causes among Medicare beneficiaries at US hospitals during the SARS-CoV-2 pandemic. JAMA Netw open. 2022;5(3):e221754–221754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8908076</ArticleId><ArticleId IdType="pubmed">35262712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal VD, Myatra SN, Divatia JV, Biswas S, Shrivastava A, Al-Ruzzieh MA, et al. The impact of COVID-19 on health care–associated infections in intensive care units in low- and middle-income countries: international nosocomial infection Control Consortium (INICC) findings. Int J Infect Dis. 2022;118:83–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8866162</ArticleId><ArticleId IdType="pubmed">35218928</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner-Lastinger LM, Pattabiraman V, Konnor RY, Patel PR, Wong E, Xu SY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Volume 43. Infection Control &amp; Hospital Epidemiology; 2022. pp. 12–25. 1.</Citation><ArticleIdList><ArticleId IdType="pubmed">34473013</ArticleId></ArticleIdList></Reference><Reference><Citation>Pérez-Granda M, Carrillo C, Rabadán P, Valerio M, Olmedo M, Muñoz P, et al. Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control. J Hosp Infect. 2022;119:149–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8498804</ArticleId><ArticleId IdType="pubmed">34627934</ArticleId></ArticleIdList></Reference><Reference><Citation>Verberk JD, van der Kooi TI, Kampstra NA, Reimes N, van Rooden SM, Hopmans TE, et al. Healthcare-associated infections in Dutch hospitals during the COVID-19 pandemic. Volume 12. Antimicrobial Resistance &amp; Infection Control; 2023. pp. 1–11. 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9813899</ArticleId><ArticleId IdType="pubmed">36604755</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan SC, Evans T, Durie ML, Secombe PJ, Pilcher D. Mortality among people admitted to Australian intensive care units for reasons other than COVID-19 during the COVID‐19 pandemic: a retrospective cohort study. Medical Journal of Australia; 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">37080906</ArticleId></ArticleIdList></Reference><Reference><Citation>Faltoni M, Catho G, Pianca E, Minka-Obama B, Zanella M-C, Chraiti M-N, et al. Catheter size and risk of short-term peripheral venous catheter-associated bloodstream infections: an observational study. Clinical Microbiology and Infection; 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">38142893</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>